Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
To examine pharmacoeconomics of IV acetaminophen (Ofirmev). Specifically, to examine its
potential to improve hospital efficiency and patient outcomes. The investigators compare the
addition of IV acetaminophen versus placebo on postoperative anesthesia care unit recovery
times, inpatient hospital length of stay (LOS), postoperative pain scores, consumption of
opiates as rescue agents and side effects among patients undergoing robotic-assisted
laparoscopic prostatectomy (RALP).